Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Timing of Antineoplastic Administration Affects Emesis

    • 1 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Timing of Antineoplastic Administration Affects Emesis. Inpharma Wkly. 581, 20 (1987). https://doi.org/10.1007/BF03291264

    Download citation

    Keywords

    • Doxorubicin
    • Bladder Cancer
    • Short Duration
    • Cancer Treatment
    • Anticancer Agent